NCT07860047
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07860047
Title Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer (ImmProCure)
Acronym ImmProCure
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University Hospital Tuebingen
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
NCT Studienzentrale; Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg NOT_YET_RECRUITING Heidelberg Baden-Wurttemberg 69120 Germany Details
CCU Transltional Immunolgy, University Hospital Tübingen RECRUITING Tübingen Baden-Wurttemberg 72076 Germany Details
Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin - Studienzentrale Onkologie NOT_YET_RECRUITING Berlin Beriln 12203 Germany Details
Universitätsklinikum Essen, Abteilung Urologie NOT_YET_RECRUITING Essen North Rhine-Westphalia 45147 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field